# Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment

> **NCT02381782** · — · COMPLETED · sponsor: **General Hospital Groeninge** · enrollment: 33 (actual)

## Conditions studied

- Hearing Loss
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02381782
- **Lead sponsor:** General Hospital Groeninge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381782, "Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT02381782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*